Rankings
Pricing
Log In
Free Trial
US-listed companies
2seventy bio, Inc.
2seventy bio, Inc.
TSVT
Market cap
$246.54M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2021
Dec 31,
2022
Net loss
-292
-254
Change in fair value of contingent consideration
0
0
Depreciation and amortization
16
12
Stock-based compensation expense
55
41
Other non-cash items
-0
-0
Prepaid expenses and other assets
-2
8
Operating lease right-of-use assets
16
35
Accounts payable
-0
0
Accrued expenses and other liabilities
16
-8
Operating lease liabilities
-16
-12
Deferred revenue
4
-23
Collaboration research advancement
7
20
Net cash used in operating activities
-207
-237
Purchases of property, plant and equipment
12
23
Purchases of marketable securities
-
146
Proceeds from maturities of marketable securities
35
180
Purchase of intangible assets
8
-
Net cash provided by (used in) investing activities
15
12
Transfers from bluebird bio
355
-
Proceeds from Issuance of Private Placement
-
166
Proceeds From Stock Options Exercised And Stock Plans
-
1
Net cash provided by financing activities
355
166
Decrease in cash, cash equivalents and restricted cash
163
-59
Capital Expenditures Incurred but Not yet Paid
4
11
Non-cash return of bRT-related assets to bluebird bio
110
-
Increase Of Right-of-Use Asset And Associated Lease Liability Due To Reassessment
175
-
Stock Issued
7
-